| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Director
1 company
William Valle is Director at TLSI. William Valle's net worth is not public. Form 4 filings only show shares in the companies where this person is an insider; those holdings are worth an estimated $290K at current prices.
Net of sales, the TLSI filings show accumulation of 30,487 shares.
William Valle has 4 Form 4 filings on record from January 2025 to May 2026, all as Director at TriSalus Life Sciences (TLSI), 2025–2026.
The 7 reported transactions were 4 option or other derivative awards, 2 stock awards and 1 open-market purchase.
Counted by filing, the open-market trades come to 1 purchase worth about $125K and no sales.
The only open-market purchase was 30,487 shares of TLSI at an average $4.10 on February 23, 2026, about $125K.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Feb 23, 2026 | TLSI Trisalus Life Sciences, Inc. | Director | Buy | 30,487 | $4.10 | $124,996.70 | New | -35.5% | - |